MLH1 and neoplasm: Though the exact approach for UTS may vary across health care systems, the first step is typically screening tumor tissue with a test for, (microsatellite instability (MSI) or with immunohistochemistry (IHC) testing) to detect the absence of one or more of the MMR proteins (MLH1, MSH2, MSH6, and PMS2).